Cargando…
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Autores principales: | Li, Zhaoqing, Chen, Cong, Chen, Lini, Hu, Dengdi, Yang, Xiqian, Zhuo, Wenying, Chen, Yongxia, Yang, Jingjing, Zhou, Yulu, Mao, Misha, Zhang, Xun, Xu, Ling, Ju, Siwei, Shen, Jun, Wang, Qinchuan, Dong, Minjun, Xie, Shuduo, Wei, Qun, Jia, Yunlu, Zhou, Jichun, Wang, Linbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959889/ https://www.ncbi.nlm.nih.gov/pubmed/35356217 http://dx.doi.org/10.3389/fonc.2022.880458 |
Ejemplares similares
-
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Targeting ferroptosis in breast cancer
por: Li, Zhaoqing, et al.
Publicado: (2020) -
Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis
por: Chen, Cong, et al.
Publicado: (2022) -
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021)